Carisma Therapeutics

Steven Kelly, CEO
Philadelphia, PA

Virtual Presentation

Carisma Therapeutics is a clinical-stage biopharmaceutical company developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors.

By using this website you agree to accept our Privacy Policy and Terms & Conditions